About W. Geho
Form D filings for Diasome Pharmaceuticals from 2009 to 2024 list W. Geho as executive officer and director.
W. Geho first appears on SEC filings in 2009.
Experience
This experience comes from SEC filings. The years are when the filings name W. Geho in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people W. Geho works with at each company, as listed on that company's latest Form D.
Diasome Pharmaceuticals, Inc. · Form D, Aug 15, 2024
PT
Peter Tollman
Director
RG
Robert Geho
Chief Executive Officer and director
FM
Frank McCaney
Director
TM
Thomas McDonald
Director
CO
Cosme Ordonez
Director